The math is simple: you're adding roughly 0.5mg every two weeks, pausing at each level until the side effect picture is clear
The MDL, now comprised of 1,521 pending cases as of March 6, 2025, alleges both companies failed to warn consumers about the risks of their diabetes and weight loss drugs, including Ozempic, Wegovy, Rybelsus, Trulicity, and Mounjaroall of which contain semaglutide as the active ingredient
Patients can search for eligible studies via: NIHR 'Be Part of Research' (www.bepartofresearch.nihr.ac.uk) the recommended UK-facing trial finder ClinicalTrials.gov the international registry listing ongoing Phase 3 and cardiovascular outcome studies of retatrutide EU Clinical Trials Information System (CTIS) for trials registered within the European regulatory framework Clinicians wishing to facilitate trial access should contact their institutional Research and Development (R&D) office
But if that could be figured out, then we may be looking at a scenario where we can employ a system like what's used to manage blood pressure or diabetes, with multiple drugs
